Best Practices in How Oncologists and Pathologists Can Work Together to Optimize Biomarker Testing for their Patients with CancerVideo Categories: 2018 ASCO Insights, Biomarkers, and Video Library
Dr Sanjiv Agarwala describes best practices developed at St. Luke’s Cancer Center, where a committee has been formed in which clinicians and pathologists meet to reach consensus on reflex testing of molecular biomarkers, as well as the value of biomarker testing in enhancing patient care.
Dr Sanjiv Agarwala discusses the usefulness of MSI and TMB as novel biomarkers for various cancer types. His argument is that the first FDA approval of a therapy based on MSI rather than tumor type makes this biomarker useful, but TMB is not yet ready for “prime time.”
Kim Popovits, Chairman, CEO and President, Genomic Health Inc., offers a definition of personal medicine in the first segment of this new video from Personalized Medicine in Oncology.